Cytokinetics (CYTK) Tops Q4 EPS by 8c
Tweet
Share
E-mailGet Alerts CYTK Hot Sheet
Price: $73.45 -2.9%
Financial Fact:
Research and development: 19.34M
Today's EPS Names:
CMCT, STEX, PWCM, More
Financial Fact:
Research and development: 19.34M
Today's EPS Names:
CMCT, STEX, PWCM, More
Join SI Premium – FREE
Cytokinetics (NASDAQ: CYTK) reported Q4 EPS of ($0.24), $0.08 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $9.8 million versus the consensus estimate of $10.49 million.
For earnings history and earnings-related data on Cytokinetics (CYTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
- Boston Omaha Corporation (BOC) Misses Q2 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
